Abhinav Acharya

Abhinav Acharya is the Elmer Lincoln Lindseth Associate Professor of Biomedical Engineering at Case Western Reserve University's Case School of Engineering and a member of the Case Comprehensive Cancer Center. His research focuses on immune engineering and immunometabolism, leveraging biomaterials to modulate immune cell metabolism for treating cancer, autoimmune disorders, and chronic inflammation. He holds appointments in both the School of Engineering and School of Medicine, reflecting his interdisciplinary work.

Education & Training:

• PhD in Biomedical Engineering (University of Florida)
• Postdoctoral Research: Georgia Institute of Technology, UC Berkeley, and University of Pittsburgh

Research Interests:

Dr. Acharya develops biomaterial systems to engineer immune responses via metabolic pathways. Current projects include metabolite-based polymers for cancer immunotherapy, covalent organic frameworks for immune modulation, and anti-inflammatory strategies for rheumatoid arthritis. His lab explores diseases such as melanoma, traumatic brain injury, and osteoarthritis, with a focus on translational therapies.

Publications & Patents:

Over 50 peer-reviewed articles and multiple patents (e.g., metabolism-targeted vaccines, wound healing polymers, and probiotic therapies). Recent work includes Nature Communications (2023), Advanced Healthcare Materials (2024), and Biomaterials Science (2022).

Grants & Awards:

Funding from NSF (CAREER), NIH, and industry partnerships. The lab spun out startups like Immunometabolix LLC for commercializing therapies.

Labs & Teams:

Runs a multidisciplinary lab with 10+ members, including PhD students, postdocs, and undergraduates. Collaborates with institutions such as Arizona State University and the University of Pittsburgh.